Search research articles
Contact Us
Filters
Showing results (21-30 of 27) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 27 results.
JCO Global Oncology
|
March 10, 2020
Treatment of Patients With Late-Stage Colorectal Cancer: ASCO Resource-Stratified Guideline
E Gabriela Chiorean, Govind Nandakumar, Temidayo Fadelu, et al.
Biorxiv : the Preprint Server for Biology
|
October 10, 2024
Endocrine persistence in ER+ breast cancer is accompanied by metabolic vulnerability in oxidative phosphorylation
Steven Tau, Mary D Chamberlin, Huijuan Yang, et al.
Cancer Research
|
January 8, 2025
Oxidative Phosphorylation Is a Metabolic Vulnerability of Endocrine Therapy-Tolerant Persister Cells in ER+ Breast Cancer
Steven Tau, Mary D Chamberlin, Huijuan Yang, et al.
Breast Cancer Research and Treatment
|
June 21, 2020
Plasma DNA as a "liquid biopsy" incompletely complements tumor biopsy for identification of mutations in a case series of four patients with oligometastatic breast cancer
Mary D Chamberlin, Jason D Wells, Kevin Shee, et al.
The Oncologist
|
July 25, 2015
Implementation of a Molecular Tumor Board: The Impact on Treatment Decisions for 35 Patients Evaluated at Dartmouth-Hitchcock Medical Center
Laura J Tafe, Ivan P Gorlov, Francine B de Abreu, et al.
JAMA Network Open
|
March 22, 2024
Telephone-Based Rehabilitation Intervention to Optimize Activity Participation After Breast Cancer: A Randomized Clinical Trial
Kathleen Doyle Lyons, Stephen B Wechsler, Deborah B Ejem, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 30, 2021
A Multicenter Phase II Trial of Ipilimumab and Nivolumab in Unresectable or Metastatic Metaplastic Breast Cancer: Cohort 36 of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART, SWOG S1609)
Sylvia Adams, Megan Othus, Sandip Pravin Patel, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 27) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 27 results.
JCO Global Oncology
|
March 10, 2020
Treatment of Patients With Late-Stage Colorectal Cancer: ASCO Resource-Stratified Guideline
E Gabriela Chiorean, Govind Nandakumar, Temidayo Fadelu, et al.
Biorxiv : the Preprint Server for Biology
|
October 10, 2024
Endocrine persistence in ER+ breast cancer is accompanied by metabolic vulnerability in oxidative phosphorylation
Steven Tau, Mary D Chamberlin, Huijuan Yang, et al.
Cancer Research
|
January 8, 2025
Oxidative Phosphorylation Is a Metabolic Vulnerability of Endocrine Therapy-Tolerant Persister Cells in ER+ Breast Cancer
Steven Tau, Mary D Chamberlin, Huijuan Yang, et al.
Breast Cancer Research and Treatment
|
June 21, 2020
Plasma DNA as a "liquid biopsy" incompletely complements tumor biopsy for identification of mutations in a case series of four patients with oligometastatic breast cancer
Mary D Chamberlin, Jason D Wells, Kevin Shee, et al.
The Oncologist
|
July 25, 2015
Implementation of a Molecular Tumor Board: The Impact on Treatment Decisions for 35 Patients Evaluated at Dartmouth-Hitchcock Medical Center
Laura J Tafe, Ivan P Gorlov, Francine B de Abreu, et al.
JAMA Network Open
|
March 22, 2024
Telephone-Based Rehabilitation Intervention to Optimize Activity Participation After Breast Cancer: A Randomized Clinical Trial
Kathleen Doyle Lyons, Stephen B Wechsler, Deborah B Ejem, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 30, 2021
A Multicenter Phase II Trial of Ipilimumab and Nivolumab in Unresectable or Metastatic Metaplastic Breast Cancer: Cohort 36 of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART, SWOG S1609)
Sylvia Adams, Megan Othus, Sandip Pravin Patel, et al.
Page
of 3